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Background: Mucosal epithelia, including those of the oviduct, secrete antimicrobial innate immune molecules
(AIIMS). These have bactericidal/bacteriostatic functions against a variety of pathogens. Among the AIIMs, sheep
β-defensin-1 (SBD-1) is one of the most potent. Even though the SBD-1 is an important AIIM and it is regulated
closely by estrogenic hormone, the regulation mechanism of 17β-estradiol has not been clearly established. We
investigated the effects of E2 and agonist or inhibitor on ovine oviduct epithelial cells in regard to SBD-1 expression
using reverse transcription quantitative PCR (RT-qPCR). In addition, three different pathways were inhibited
separately or simultaneously to confirm the effect of different inhibitors in the regulation mechanism.
Results: 17beta-estradiol (E2) induced release of SBD-1 in ovine oviduct epithelial cells. SBD-1 expression was
mediated through G-protein-coupled receptor 30 (GPR30) and Estrogen Receptors (ERs) activation in ovine oviduct
epithelial cell. Inhibition of gene expression of protein kinase A (PKA), protein kinase C (PKC), and nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB) led to a decreased SBD-1 expression.
Conclusions: Taken together, E2-induced up-regulation of SBD-1 expressions were GPR30-dependent during
prophase and ERs-dependent during later-stage in ovine oviduct epithelial cells, and we assume that the effect was
completed by the PKA, PKC, and NF-κB pathways simultaneous.
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Ovine oviduct epithelial cells are effective barriers for
microorganisms and actively participate in the initiation
of innate host defense. Unfortunately, salpingitis is the
one of most common and serious infections in repro-
ductive system diseases [1]. However, there has been a
dramatic worldwide increase in antibiotic resistance in
pathogens in the past several decades. Thus, there is an
urgent need to develop new and innovative, non-
antibiotic approaches to prevent and manage this disease
[2,3]. Defensins are antimicrobial peptides of innate im-
munity functioning by non-specific binding to anionic
phospholipids in bacterial membranes.* Correspondence: guifangcao@hotmail.com; navy1973@163.com
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reproduction in any medium, provided the orβ-defensins are produced directly by epithelial cells,
and combat infection both through direct microbicidal
action and by modulation of cell-mediated immunity
[4-7]. These peptides are involved in the innate immun-
ity mechanisms and act directly against bacteria,
viruses, and fungi, due to their bactericidal and cyto-
toxic activity [8]. Moreover, they have been suggested
as effector molecules in host defense, interacting with
many target cells and tissues [9]. So far, only two β-
defensin genes have been identified in sheep: β-defensin
1 (SBD-1) and β-defensin 2 (SBD-2), although genomic
studies suggest more have yet to be discovered [10]. Re-
cent studies have revealed that the SBD-1 is an import-
ant component of the innate immune response of the
ovine oviduct.
Nonetheless, there is a paucity of information about
the role and regulation of the expression of the oviduct
SBD-1 gene in ovine and, in particular, whether E2
modulate its expression. In the present study, the ex-
pression of mRNA SBD-1 was studied by a PCR (RT-d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Since previous studies have demonstrated that E2 pro-
vides a stimulus that may regulate defensins, this study
investigated the effect of three pathways, PKA, PKC and
NF-κB, in SBD-1 expression by oviduct epithelial cul-
tured cells.Results
E2 up-regulates SBD-1 expression in ovine oviduct
epithelial cells
To find out whether E2 can increase expression of SBD-
1 mRNA in different concentrations and times, we trea-
ted ovine oviduct epithelial cells with different concen-
trations E2 and different times. Figure 1C&D shows the
kinetics of SBD-1 expression. As is evident from the fig-
ure, the induction of SBD-1 mRNA expression was very
rapid after the cells had been treated for 2 h and the
greatest induction was observed at 6 h, which suggests
that the highest expression levels were around 6 h.
Afterwards, although the up-regulation was continuing,
the enhanced amplitude gradually decreased, and the
lowest induction was at 48 h (Figure 1C). Besides, the
concentration of 10-8 M provided the greatest induc-
tion at every time point except at 48 h, which suggests
that the optimum concentration of E2 for the cells is
10-8 M (Figure 1D). Therefore, we treated the cells
with E2 (10
-8 M) to seek the time point of the greatest
induction of SBD-1 expression. Figure 1E shows that
the greatest induction of SBD-1 expression was
observed at 3.5 h and the induction of SBD-1 expres-
sion has significant differences from 1.5 to 10.5 h. The
change of SBD-1 expression level was especially preva-
lent between 2.5 to 6.5 h.SBD-1 expression was mediated through GPR30 and ERs
activation in ovine oviduct epithelial cells
Recent studies showed that activation of GPR30 and ERs
controls estrogen-responsiveness [11,12]. Therefore, to
further investigate a possible role of GPR30 and ERs ac-
tivation for E2-dependent SBD-1 expression, we pre-
incubated ovine oviduct epithelial cells with the high-
affinity agonist G1 for GPR30 and the inhibitor ICI
182,780 to prevent ERs bind with E2. As shown in
Figure 2A&C, treatment of cells with E2 and G1 resulted
in SBD-1 expression increasing from 2.5 to 5.5 h and the
effect is not obvious from 6.5 to 7.5 h. Inhibiting ERs ac-
tivation inhibited the SBD-1 expression (Figure 2B) in
E2-treated cells from 5.5 to 7.5 h, whereas SBD-1 expres-
sion increased from 2.5 to 3.5 h (Figure 2D). Our data
demonstrated that activation of GPR30 and ERs by E2
was important for SBD-1 expression in ovine oviduct
epithelial cells.The PKA, PKC and NF-κB pathways were essential in
E2-induced up-regulation of SBD-1 expression
Having demonstrated that the greatest induction was
observed at 3.5 h in E2-induced up-regulation of SBD-1
expression, we went on to elucidate the pathway by
which signal was transduced to the nucleus. Based on
the putative mechanisms of estrogen action [13], we
tested the hypothesis that the PKA, PKC and NF-κB
pathways might be essential in E2-induced up-regulation
of SBD-1 expression using PKA inhibitor H-89, PKC in-
hibitor H-7 and NF-κB inhibitor PDTC. Figure 3 shows
that the SBD-1 expression was significantly reduced
when treated with inhibitor or inhibitors with no differ-
ence compared to the control group.
Discussion
Antimicrobial innate immune molecules produced by
the epithelial cells provide the host with a constitutive or
immediately inducible defense mechanism against invad-
ing pathogens [14]. Meanwhile, non-inflamed tubal and
middle ear mucosa have been shown to contain rela-
tively few immunocytes [15,16]. Furthermore, because of
the under-developed and premature adaptive immune
system in young animals, the role of AIIMs in protecting
against pathogens becomes important. This suggests that
AIIMs protect the body during the neonatal and early
postnatal periods when the adaptive immunity is not yet
fully developed.
Among the AIIMs, defensins and cathelicidins are the
dominant antimicrobial peptides found in neutrophils
and epithelia as components of the early host defenses
of mammals against infection, and these peptides have
potent microbicidal activity against prokaryotic and
eukaryotic pathogens as well as viruses [17]. The expres-
sion of defensin in epithelial cells is mediated by certain
hormones and is closely related to estrogenic hormone
and progesterone [18]. This suggests that E2 might be
important in the modulation of ovine defensin expres-
sion in ovine oviduct epithelial cells. However, there is
little information on how the E2 regulates the expression
of defensins in ovine oviduct epithelial cells by E2.
We demonstrate that the gene of SBD-1 was expressed
in ovine oviduct epithelial cells through the RT-PCR ana-
lysis and sequencing. In addition, using qPCR, there was
a single peak in every dissociation curve (Figure 1A&B),
and the amplification efficiencies of SBD-1 and β-actin
were 0.996 and 0.990. Meanwhile, both slopes were −3.3.
Based on this we also demonstrated that E2 could up-
regulate the expression of SBD-1, especially when treated
with 10-8 M E2 (Figure 1C&D). The mechanism by which
E2 induces or activates the expression of SBD-1 is not
precisely understood, but our data showed that the ex-
pression of SBD-1 still occurs in ovine oviduct epithelial
cells left untreated. Therefore, E2 may be not necessary
Figure 1 E2 up-regulates SBD-1 gene expression in ovine oviduct epithelial cells. Through QPCR, these primers are valid because of the
single peak in every dissociation curve using SYBRW Green I. (A, B) Different concentrations of E2 treatment of ovine oviduct epithelial cells
increased the mRNA levels of SBD-1. The z-axis or y-axis represents the signal derived from quantitative PCR on total RNA extracted from the
cells. (C) The x-axis shows the time during which the cells were exposed to 10-8 M E2. Furthermore, a blank control (water substituted for cDNA)
was included in each qPCR reaction mixture, and a control was set up containing water instead of E2 in every group. (E) The greatest induction
was observed in the 10-8 M E2 treated group at 3.5 h. Different concentrations of E2 were added to the various groups, and total RNA extracted
at the indicated time points from the ovine oviduct epithelial cells (n = 3). Values are given as mean± standard deviation. (*: p < 0.05 vs control,
**: p < 0.01 vs control).
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Figure 2 E2-induced SBD-1 expression in ovine oviduct epithelial cells requires GPR30 and ERs. (A) The cells were treated with the GPR30
agonist G1 (10-7 M) and E2 (10
-8 M). (B) Other groups of cells were incubated with the inhibitor ICI 182,780 (Anti-ER 10-7 M, 1 h) and then added
with E2 (10
-8 M). Furthermore, a blank control (water substituted for cDNA) was included in each qPCR reaction mixture, and a control was set up
containing water instead of E2 or/and G1/ ICI 182,178 in every group. (C, D) In the magnified inset, there were statistically significant changes
between the two different treatments at different times from A or B. Total RNA extracted at the indicated times from the ovine oviduct epithelial
cells (n = 3). Values are given as mean± standard deviation. (*: p < 0.05 vs control, **: p < 0.01 vs control).
Wen et al. BMC Veterinary Research 2012, 8:143 Page 4 of 8
http://www.biomedcentral.com/1746-6148/8/143for the expression of SBD-1 but nay rather play a role as
a promoting factor. Moreover, after stimulation with E2
at 10-8 M, the effect continued for at least 24 h
(Figure 1C&D) and peaked at 3.5 h, while, the highest ex-
pression level had been sustained for 4 h from 2.5 to
6.5 h (Figure 1E). This data suggests that the expression
was activated and reached it’s highest level simultan-
eously, but only for a short time, after which time it con-
tinued as a reduced-level, which was still much higher
compared with the non-treated control. This shows that
there might be a fast pathway, which could be activated
quickly, in the expression of SBD-1 by E2.
Previous studies have suggested that the putative
mechanisms of estrogen action have two mechanisms: a
Non Classical Genomic Mechanism and a ClassicalGenomic Mechanism. Meanwhile, GPR30 and ERs
might play important roles in the two mechanisms [13].
Based on these results, we investigated the role and
identity of GPR30 and ERs in the modulation of SBD-1
expression by E2 in ovine oviduct epithelial cells. We
noted that the expression increased after addition of E2
and G1 from 2.5 to 5.5 h and with no change in the E2
only treatment from 6.5 to 7.5 h (Figure 2A&C). Mean-
while, after addition of E2 and ICI 182,780, the expres-
sion diminished quickly from 5.5 to 7.5 h (Figure 2B),
however, the expression increased from 2.5 to 3.5 h
(Figure 2D). This is consistent with the fact that ICI
182,780 is also an agonist at the membrane estrogen re-
ceptor GPR30 [19]. These results suggest that E2-
induced up-regulation of SBD-1 mRNA expression was
Figure 3 E2-induced SBD-1 expression in ovine oviduct epithelial cells via cAMP/PKA pathway, PKC pathway and NF-κB pathway. Cells
treated with the PKA (H-89, 50 μM), the PKC (H-7, 50 μM), and NF-κB inhibitors (PDTC, 50 μM) showed significantly lower SBD-1 expression
compared to the control. Furthermore, a blank control (water substituted for cDNA) was included in each qPCR reaction mixture, and a control
was set up containing water instead of E2 or/and inhibitor(s) in every group. Total RNA extracted at the indicated time points from the ovine
oviduct epithelial cells (n = 3). Values are given as mean± standard deviation. (*: p < 0.05 vs control, **: p < 0.01 vs control).
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cells at different times. GPR30 plays an important role
in Non Classical Genomic Mechanism, activating rapid
pathways, while ERs acts with a Classical Genomic
Mechanism controlling gene transcription.
In the Non Classical Genomic Mechanism, the cAMP/
PKA pathways [20], PKC pathway [21] and NF-κB path-
way [22,23] play important roles in the putative mechan-
isms of estrogen action [13]. Our data showed that there
was almost no difference between the untreated and trea-
ted cells, which were added with the inhibitors of H-89,
H-7, and PDTC either individually or in combination for
3.5 h (Figure 3). These results suggest that the three
pathways were indispensable for the expression of SBD-1
by E2 in ovine oviduct epithelial cells. Furthermore, we
also conclude that the three pathways should be activated
simultaneously, or otherwise there would be no effect on
the E2-induced up-regulation of SBD-1 expression.
Conclusion
In conclusion, we found that in ovine oviduct epithelial
cells E2-induced up-regulation of SBD-1 expression was
GPR30-dependent during prophase and ERs-dependent
during later-stage. Expression of SBD-1 included activa-
tion of the cAMP/PKA pathway, PKC pathway and NF-
κB pathway via the Non Classical Genomic Mechanism,whereas the precondition that all three pathways were
activated simultaneously was essential for this process.
Since control of the immune response is crucial to pre-
vent excessive tissue damage and to assure bacterial
clearance in salpingitis, the mechanism described above




This study involved five ewes of the Mongolia breed,
13–15 months old. All sheep were free of parasitic and
infectious diseases. The animals were purchased from
Tecon Group located in the Urumqi (Xinjiang Autono-
mous Region, PR China). All animals were cared for by
trained animal keepers and fed with hay and a commer-
cial pelleted ration. Water and mineralized salt were
available ad libitum. All experimental animals in this
study were approved by the Institutional Animal Care
and Use Committee (IACUC) at Inner Mongolia Agri-
culture University.
Animal handling, euthanasia and experimental proce-
dures were carried out in compliance with the Tecon
Group regulations (Licence NO. SYXK, Xin, 2010–0005),
with the approval of the Animal Ethics Committee
of the Inner Mongolia Agriculture University of Inner
Table 1 The primers
Gene (Accession No.) Primers (50-30) Product size
SBD-1(U75250)
F GGCTCCATCACCTGCTCCTC 206 bpa
R CGTCTTCGCCTTCTGTTACTTCTT
β-actin(U39357)
F GTCACCAACTGGGACGACA 208 bp
R AGGCGTACAGGGACAGCA
a bp, base pairs.
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of barbiturate overdose followed by exsanguination and
immediate removal of the oviducts.
Materials
The ERs inhibitor (ICI 182,780, Cat.No. 1047) was pur-
chased from Tocris (Cambridge, UK), the PKA inhibitor
(H-89, Cat.No. B1427), the PKC inhibitor (H-7, Cat.No.
I7016), the NF-κB inhibitor (PDTC, Cat.No. P8765) were
purchased from Sigma Chem. Co. (Munich, Germany),
the GPR30 agonist (G1, Cat.No. 371705) was purchased
from Merck (Darmstadt, Germany). All other chemicals
used were of analytical grade and obtained from com-
mercial sources.
Cell culture
Ovine oviduct epithelial cells were isolated based on the
protocol by R. Ian Freshney and Mary G. Freshney [24],
and all the procedures were performed under sterile
conditions. Briefly, ovine oviducts were removed imme-
diately after slaughter and placed in cold PBS supple-
mented with 1% penicillin/streptomycin (Sigma). Once
in the laboratory, oviduct tissue, which was bisected lon-
gitudinally by ophthalmology shear, was placed in HBSS
(Sigma) with 0.05% pancreatin (Sigma) and 0.02% EDTA
(Sigma) and incubated at 37°C for 12 min. After that the
inner surface of the oviducts were lightly scraped with a
scalpel in Hanks balanced salt solution. Tissue was
removed and scraped material (the cells) was agitated by
pipetting up and down using a Movette pipette; cells
were centrifuged at 800 × g for 3 min and resuspended
in HBSS. Repetitions of this step were performed until
the HBSS remained almost clear. (This usually takes
about 3 repeats of the washing process.) Cells were
placed into 25 cm2 cell culture flasks (Corning Inc.,
Corning, NY) with phenol red-free DMEM/F-12
(Thermo) plus 15% (vol/vol) heat-inactivated FCS,
100 μg/ml streptomycin and 100 U/ml penicillin. Cells
had been grown for 48 to 72 h until 80 – 90% and pas-
saged into six-well cell culture plates in triplicate. For
studying the effect of E2, the cells were washed with
serum-free DMEM/F-12 and placed under serum-free
conditions for 12 h, and were pretreated for one hour
with or without chemical agonist of GPR30 (G1) and
chemical inhibitors including ICI 182,780, H-89, H-7,
PDTC. All cells were maintained in a humidified atmos-
phere of 5% CO2 and 95% air.
RNA and cDNA preparation
Total RNA from cells was extracted using RNAiso Plus
(TaKaRa, Japan) according to manufacturer’s protocol.
1 ml of RNAiso Plus was used for each 10 cm2-well of
cells and lysed in an RNase free environment. Chloro-
form was then added (200 μl for each lysate) and thesamples were centrifuged at high speed for 15 minutes
at 4°C. The aqueous layer was then transferred into a
new Eppendorf tube and RNA was precipitated with iso-
propanol followed by one wash using 70% ethanol. The
RNA precipitate was then dissolved in 15–20 μl of
RNase-free water. Digestion of genomic DNA was per-
formed using DNase I (Sigma). The integrity of the
extracted RNA was examined by 1% agarose gel electro-
phoresis; the quantity and purity were assessed by meas-
uring absorbance using a BioPhotometer plus
(Eppendorf, Germany). After that, only samples with an
OD 260/230 ratio greater than 1.6 and an OD 260/280
ratio between 1.8 and 2 were included in subsequent
studies. The cDNA was synthesized in a volume of 20 μl
using 1 μg of total RNA from each sample and Prime-
ScriptTM RT reagent Kit (TaKaRa, Japan) in time, and all
cDNA was stored at −20°C.
Efficiency Measurements and Real-Time qPCR
Amplification efficiency (Eff = 10(−1/slope)-1) values were
determined in parallel runs with cDNA samples for each
gene during RT-qPCR. Preliminary qPCR assays, using
the Cq slope method described below, were used to
measure the two genes’ amplification efficiency. This
method involves generating a dilution series of the target
template and determining the Cq value for each dilution.
A plot of Cq versus log cDNA concentration was con-
structed. All primers (Table 1), which were designed and
synthesized from Sangon Biotech (Shanghai, China),
spanned the exon borders of the gene to avoid amplifica-
tion of any contaminating genomic DNA.
Quantification of SBD-1 and reference gene transcript
copy number for the cDNA
Samples were determined by RT-qPCR analysis carried
out on the iCycler iQ5™ Real-Time PCR Detection Sys-
tem (Bio-Rad, Hercules, CA, USA) using gene specific
primers, according to the manufacturer’s instructions.
Each 20 μl reaction was run in triplicate and consisted
of: SYBRW Premix Ex TaqTM II (2×, Perfect Real Time,
TakaRa, Japan) 10.0 μl, 0.4 μl (10 μM) each of the for-
ward and reverse primers, cDNA template 2.0 μl, and
ddH2O 7.2 μl used to normalize the fluorescent reporter
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sisted of 1 cycle at 95°C (30 seconds); 50 cycles of 95°C
(20 seconds), 63°C (30 seconds), 72°C (20 seconds), 82°C
(10 seconds); 1 cycle at 72°C (7 minutes); followed by a
51-step melting-curve analysis (initial temperature 70°C,
increasing 0.5°C every 6 seconds), including a negative
control consisting of PCR-grade water. Data analysis was
performed using the Bio-Rad iQ5 Software 2.1 and the
results were expressed as fold-change in relative mRNA
expression level, calculated using the ΔΔCt method with
β-actin as the reference gene and the non-treated cells as
baseline. Dissociation curves and 1% agarose gel electro-
phoresis, containing ethidium bromide were visualized
under ultraviolet light and used to verify the presence of
single PCR products. After that, the amplicons were
cloned into pMD19-T vector (TaKaRa, Japan) and con-
firmed by sequencing (Shanghai, China).
Statistical analysis
Data were analyzed using the SPSS Statistics 17.0 (SPSS
Inc., Chicago, IL, USA). Results are expressed as mean ±
SD of at least three independent experiments. Differ-
ences between control and samples were compared by
matched pair t-test and were considered significant
when the P value was ≤ 0.05.
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